Erratum

Clinical use of Rivaroxaban: Pharmacokinetic and pharmacodynamic rationale for dosing regimens in different indications (Drugs (2014) 74:14 (15871603) DOI 10.1007/s40265-014-0278-5)

Toby Trujillo, Paul P Dobesh

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalDrugs
Volume74
Issue number15
DOIs
StatePublished - Oct 17 2014

Fingerprint

Pharmacokinetics
Pharmaceutical Preparations
Rivaroxaban

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

@article{8db0d622c1e6437dae917ba97900b45c,
title = "Erratum: Clinical use of Rivaroxaban: Pharmacokinetic and pharmacodynamic rationale for dosing regimens in different indications (Drugs (2014) 74:14 (15871603) DOI 10.1007/s40265-014-0278-5)",
author = "Toby Trujillo and Dobesh, {Paul P}",
year = "2014",
month = "10",
day = "17",
doi = "10.1007/s40265-014-0311-8",
language = "English (US)",
volume = "74",
journal = "Drugs",
issn = "0012-6667",
publisher = "Adis International Ltd",
number = "15",

}

TY - JOUR

T1 - Erratum

T2 - Clinical use of Rivaroxaban: Pharmacokinetic and pharmacodynamic rationale for dosing regimens in different indications (Drugs (2014) 74:14 (15871603) DOI 10.1007/s40265-014-0278-5)

AU - Trujillo, Toby

AU - Dobesh, Paul P

PY - 2014/10/17

Y1 - 2014/10/17

UR - http://www.scopus.com/inward/record.url?scp=84922100783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922100783&partnerID=8YFLogxK

U2 - 10.1007/s40265-014-0311-8

DO - 10.1007/s40265-014-0311-8

M3 - Comment/debate

VL - 74

JO - Drugs

JF - Drugs

SN - 0012-6667

IS - 15

ER -